$80.69
1.47%
Nasdaq, Nov 20, 03:59 pm EST. Closed.
ISIN
US36266G1076
Symbol
GEHC

GE HealthCare Technologies Stock price

$80.64
+10.41 14.82% 1M
+16.38 25.49% 6M
-1.38 1.68% YTD
+5.89 7.88% 1Y
+7.31 9.97% 3Y
+20.64 34.40% 5Y
+20.64 34.40% 10Y
+20.64 34.40% 20Y
Nasdaq, Closing price Fri, Nov 20 2026
-1.25 1.53%
ISIN
US36266G1076
Symbol
GEHC

AI Insights on GE HealthCare Technologies Insights AI Insights on GE HealthCare Technologies

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Create a Free Account to create an GE HealthCare Technologies alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Key metrics

Basic
Market capitalization
$36.5b
Enterprise Value
$43.7b
Net debt
$7.2b
Cash
$2.8b
Shares outstanding
452.1m
Valuation
P/E
17.0
P/S | estimate
1.7 | 1.6
EV/Sales | estimate
2.0 | 2.0
EV/FCF | ex SBC
23.1 | 25.1
P/B
3.1
Dividends
DPS
$0.15
Yield 1Y | 5Y
0.2% | 0.1%
Growth 1Y | 5Y
3.6% | -
Payout 1Y | 3Y
3.1% | 2.9%
Increased
4 Years
Financials
Revenue | estimate
$21.6b | $22.3b
EBITDA
$3.5b
EBIT
$2.9b
Net Income
$2.2b
Free Cash Flow | ex SBC
$1.9b | $1.7b
Growth
Revenue | estimate
6.9% | 8.1%
EBITDA
6.0%
EBIT
5.4%
Net Income
-2.8%
Free Cash Flow
34.9%
Margin
Gross
39.9%
EBITDA
16.2%
EBIT
13.3%
Net
10.0%
Free Cash Flow | ex SBC
8.7% | 8.0%
Financial Health
Equity Ratio
28.1%
Return on Equity
20.1%
ROCE
9.8%
ROIC
8.0%
Debt/Equity
0.9
Share-Based Compensation & Dilution
SBC | % of Revenue
$152.0m | 0.7%
SBC as % of FCF
8.0%
SBC Growth 1Y
19.7%
Share Count Growth 1Y
-0.7%
Shareholder Yield
0.9%
More
EPS
$4.8
FCF per Share
$4.2
Short interest
4.6%
Employees
54k
Rev per Employee
$380.0k

GE HealthCare Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a GE HealthCare Technologies forecast:

21x Buy
72%
8x Hold
28%

Analyst Opinions

29 Analysts have issued a GE HealthCare Technologies forecast:

Buy
72%
Hold
28%

GE HealthCare Technologies Events

Past Events
OCT
28
Q3 2026 Earnings Call
25 days ago
SEP
9
Wells Fargo 21st Annual Healthcare Conference
2 months ago
JUL
29
Q2 2026 Earnings Call
4 months ago
JUN
3
Jefferies Global Healthcare Conference 2026
6 months ago
MAY
12
Bank of America Global Healthcare Conference 2026
6 months ago
APR
29
Q1 2026 Earnings Call
7 months ago
MAR
10
Barclays 28th Annual Global Healthcare Conference
9 months ago
FEB
26
Citi’s 2026 Unplugged MedTech and Life Sciences Access Day
9 months ago
FEB
4
Q4 2025 Earnings Call
10 months ago
JAN
13
44th Annual J.P. Morgan Healthcare Conference
10 months ago
NOV
18
Jefferies London Healthcare Conference 2025
about one year ago
OCT
29
Q3 2025 Earnings Call
about one year ago

Financial data from GE HealthCare Technologies

Sep '26
+/-
%
21,637 21,637
7% 7%
100%
- Direct Costs 12,995 12,995
8% 8%
60%
8,642 8,642
5% 5%
40%
- Selling and Administrative Expenses 4,446 4,446
5% 5%
21%
- Research and Development Expense 1,311 1,311
2% 2%
6%
3,508 3,508
6% 6%
16%
- Depreciation and Amortization 622 622
9% 9%
3%
EBIT (Operating Income) EBIT 2,886 2,886
5% 5%
13%
Net Profit 2,154 2,154
3% 3%
10%

In millions USD.

Don't miss a Thing! We will send you all news about GE HealthCare Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GE HealthCare Technologies Stock News

Neutral
Business Wire
●
2 days ago
CHICAGO--(BUSINESS WIRE)--The GE HealthCare Foundation today announced its 2026 cohort of grant recipients, supporting organizations whose work will help expand access to lifesaving care for mothers and children around the world. This year's grantees are focused on building sustainable, technology-enabled healthcare infrastructure, equipping frontline healthcare workers with point-of-care diagn...
Neutral
Business Wire
●
2 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced two new capabilities for Imaging 360, AI assistant and AI-assisted protocoling. The Imaging 360 AI assistant and AI-assist protocoling are designed to help imaging teams quickly find answers to protocol-related questions and support protocoling for CT and MR exams. Radiology departments manage complex workflows across sites,...
Neutral
Business Wire
●
3 days ago
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based magnetic resonance imaging (MRI) contrast agent (MBCA). If approved, MBCAs could offer an alternative ...
More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office United States
CEO Mr. Arduini
Employees 54,000
Founded 2022
Website www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today